Paramount Peptides
Paramount Peptides shows its clearest purity-focus evidence in Semaglutide and Retatrutide, with Ipamorelin also mostly recovering after a borderline miss. The record is dispersed: CJC-1295, BPC-157 and Survodutide carry repeated purity/fill issues, while missing batch IDs, overfills and some dated or narrow batch evidence temper confidence.
We investigated who actually operates Paramount Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Paramount Peptides rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 2 Feb 2026 | Fail | Tirzepatide Paramount Peptides | lab name | View COA | |||
| 6 Dec 2025 | Pass | Retatrutide Paramount Peptides | lab name | View COA | |||
| 6 Dec 2025 | Pass | Retatrutide Paramount Peptides | lab name | View COA | |||
| 6 Dec 2025 | Pass | Retatrutide Paramount Peptides | lab name | View COA | |||
| 3 Oct 2025 | Pass | BPC-157 Paramount Peptides | lab name | View COA | |||
| 16 Jul 2025 | Pass | Tirzepatide Paramount Peptides | lab name | View COA | |||
| 10 Jul 2025 | Fail | BPC-157 Paramount Peptides | lab name | View COA | |||
| 20 May 2025 | Fail | CJC-1295 (DAC) Paramount Peptides | lab name | View COA | |||
| 20 May 2025 | Fail | CJC-1295 (DAC) Paramount Peptides | lab name | View COA | |||
| 7 May 2025 | Pass | Tirzepatide Paramount Peptides | lab name | View COA | |||
About Paramount Peptides test results from Finnrick
Paramount Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 65 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Paramount Peptides peptides in this dataset are Semaglutide (9 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 65 recent tests.